These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 25721120

  • 1. Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
    Pekar-Zlotin M, Hirsch FR, Soussan-Gutman L, Ilouze M, Dvir A, Boyle T, Wynes M, Miller VA, Lipson D, Palmer GA, Ali SM, Dekel S, Brenner R, Bunn PA, Peled N.
    Oncologist; 2015 Mar; 20(3):316-22. PubMed ID: 25721120
    [Abstract] [Full Text] [Related]

  • 2. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.
    Li W, Zhang J, Guo L, Chuai S, Shan L, Ying J.
    J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
    [Abstract] [Full Text] [Related]

  • 3. Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative.
    Ma D, Wang Z, Yang L, Mu X, Wang Y, Zhao X, Li J, Lin D.
    Oncotarget; 2016 Sep 27; 7(39):64410-64420. PubMed ID: 27418132
    [Abstract] [Full Text] [Related]

  • 4. The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer.
    Sullivan HC, Fisher KE, Hoffa AL, Wang J, Saxe D, Siddiqui MT, Cohen C.
    Appl Immunohistochem Mol Morphol; 2015 Apr 27; 23(4):239-44. PubMed ID: 25265433
    [Abstract] [Full Text] [Related]

  • 5. [ALK fusion gene assessment by fully automatic immunohistochemistry in non-small cell lung cancer].
    Guo L, Liu X, Qiu T, Ling Y, Shan L, Xie Y.
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb 27; 43(2):95-8. PubMed ID: 24742568
    [Abstract] [Full Text] [Related]

  • 6. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF, Tong JH, Yeung KS, Lung RW, Law PP, Chau SL, Kang W, Tong CY, Chow C, Chan AW, Leung LK, Mok TS.
    J Thorac Oncol; 2013 Jul 27; 8(7):883-91. PubMed ID: 23625156
    [Abstract] [Full Text] [Related]

  • 7. Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.
    Lin C, Shi X, Yang S, Zhao J, He Q, Jin Y, Yu X.
    Lung Cancer; 2019 May 27; 131():62-68. PubMed ID: 31027700
    [Abstract] [Full Text] [Related]

  • 8. ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer.
    McLeer-Florin A, Duruisseaux M, Pinsolle J, Dubourd S, Mondet J, Phillips Houlbracq M, Magnat N, Fauré J, Chatagnon A, de Fraipont F, Giaj Levra M, Toffart AC, Ferretti G, Hainaut P, Brambilla E, Moro-Sibilot D, Lantuejoul S.
    Lung Cancer; 2018 Feb 27; 116():15-24. PubMed ID: 29413046
    [Abstract] [Full Text] [Related]

  • 9. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
    Paik JH, Choe G, Kim H, Choe JY, Lee HJ, Lee CT, Lee JS, Jheon S, Chung JH.
    J Thorac Oncol; 2011 Mar 27; 6(3):466-72. PubMed ID: 21258247
    [Abstract] [Full Text] [Related]

  • 10. Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma.
    Rosenblum F, Hutchinson LM, Garver J, Woda B, Cosar E, Kurian EM.
    Cancer Cytopathol; 2014 Nov 27; 122(11):810-21. PubMed ID: 25099128
    [Abstract] [Full Text] [Related]

  • 11. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening.
    Lee J, Kim HC, Hong JY, Wang K, Kim SY, Jang J, Kim ST, Park JO, Lim HY, Kang WK, Park YS, Lee J, Lee WY, Park YA, Huh JW, Yun SH, Do IG, Kim SH, Balasubramanian S, Stephens PJ, Ross JS, Li GG, Hornby Z, Ali SM, Miller VA, Kim KM, Ou SH.
    Oncotarget; 2015 Sep 15; 6(27):24320-32. PubMed ID: 26172300
    [Abstract] [Full Text] [Related]

  • 12. ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization.
    Williams AS, Greer W, Bethune D, Craddock KJ, Flowerdew G, Xu Z.
    Virchows Arch; 2016 Nov 15; 469(5):533-540. PubMed ID: 27562706
    [Abstract] [Full Text] [Related]

  • 13. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
    Vollbrecht C, Lenze D, Hummel M, Lehmann A, Moebs M, Frost N, Jurmeister P, Schweizer L, Kellner U, Dietel M, von Laffert M.
    BMC Cancer; 2018 Nov 22; 18(1):1158. PubMed ID: 30466405
    [Abstract] [Full Text] [Related]

  • 14. Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma.
    Jang JS, Wang X, Vedell PT, Wen J, Zhang J, Ellison DW, Evans JM, Johnson SH, Yang P, Sukov WR, Oliveira AM, Vasmatzis G, Sun Z, Jen J, Yi ES.
    J Thorac Oncol; 2016 Nov 22; 11(11):1891-1900. PubMed ID: 27343444
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, immunohistochemistry, and real-time quantitative RT- PCR on paraffin-embedded tissues.
    Zhang YG, Jin ML, Li L, Zhao HY, Zeng X, Jiang L, Wei P, Diao XL, Li X, Cao Q, Tian XX.
    PLoS One; 2013 Nov 22; 8(5):e64821. PubMed ID: 23741400
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non-Small Cell Lung Cancer.
    Cruz-Rico G, Avilés-Salas A, Segura-González M, Espinosa-García AM, Ramírez-Tirado LA, Morales-Oyarvide V, Rojas-Marín C, Cardona AF, Arrieta O.
    Am J Clin Oncol; 2017 Dec 22; 40(6):631-638. PubMed ID: 26270443
    [Abstract] [Full Text] [Related]

  • 17. ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
    Dacic S, Villaruz LC, Abberbock S, Mahaffey A, Incharoen P, Nikiforova MN.
    Oncotarget; 2016 Dec 13; 7(50):82943-82952. PubMed ID: 27769042
    [Abstract] [Full Text] [Related]

  • 18. ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.
    Alì G, Proietti A, Pelliccioni S, Niccoli C, Lupi C, Sensi E, Giannini R, Borrelli N, Menghi M, Chella A, Ribechini A, Cappuzzo F, Melfi F, Lucchi M, Mussi A, Fontanini G.
    Arch Pathol Lab Med; 2014 Nov 13; 138(11):1449-58. PubMed ID: 24885803
    [Abstract] [Full Text] [Related]

  • 19. A comparative analysis of immunohistochemistry and fluorescent in situ hybridization assay to detect anaplastic lymphoma kinase status in lung adenocarcinoma cases: A search for a testing algorithm.
    Wagle PB, Jambhekar NA, Kumar R, Prabhash K, Pramesh CS, Desai SB, Noronha V, Karimundackal G, Shah A, Joshi A, Laskar SG, Jiwnani S, Pai T, Agarwal JP.
    Indian J Cancer; 2017 Nov 13; 54(1):148-154. PubMed ID: 29199679
    [Abstract] [Full Text] [Related]

  • 20. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
    Kim H, Yoo SB, Choe JY, Paik JH, Xu X, Nitta H, Zhang W, Grogan TM, Lee CT, Jheon S, Chung JH.
    J Thorac Oncol; 2011 Aug 13; 6(8):1359-66. PubMed ID: 21587085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.